- Home
- FORTY vs DRRX Comparison
FORTY vs DRRX Comparison
Compare FORTY & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORTY
- DRRX
- Stock Information
- Founded
- FORTY 1985
- DRRX 1998
- Country
- FORTY Israel
- DRRX United States
- Employees
- FORTY N/A
- DRRX N/A
- Industry
- FORTY EDP Services
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- FORTY Technology
- DRRX Health Care
- Exchange
- FORTY Nasdaq
- DRRX Nasdaq
- Market Cap
- FORTY N/A
- DRRX 59.3M
- IPO Year
- FORTY 1997
- DRRX 2000
- Fundamental
- Price
- FORTY $129.13
- DRRX $1.92
- Analyst Decision
- FORTY
- DRRX Hold
- Analyst Count
- FORTY 0
- DRRX 1
- Target Price
- FORTY N/A
- DRRX N/A
- AVG Volume (30 Days)
- FORTY 432.0
- DRRX 487.4K
- Earning Date
- FORTY 08-19-2025
- DRRX 08-12-2025
- Dividend Yield
- FORTY 0.78%
- DRRX N/A
- EPS Growth
- FORTY 15.06
- DRRX N/A
- EPS
- FORTY 4.97
- DRRX N/A
- Revenue
- FORTY $2,889,481,000.00
- DRRX $1,657,000.00
- Revenue This Year
- FORTY N/A
- DRRX N/A
- Revenue Next Year
- FORTY N/A
- DRRX $673.00
- P/E Ratio
- FORTY $25.34
- DRRX N/A
- Revenue Growth
- FORTY 8.58
- DRRX N/A
- 52 Week Low
- FORTY $70.52
- DRRX $0.48
- 52 Week High
- FORTY $134.96
- DRRX $2.64
- Technical
- Relative Strength Index (RSI)
- FORTY 57.57
- DRRX 78.08
- Support Level
- FORTY $128.00
- DRRX $1.86
- Resistance Level
- FORTY $131.25
- DRRX $1.96
- Average True Range (ATR)
- FORTY 0.55
- DRRX 0.04
- MACD
- FORTY 0.88
- DRRX -0.04
- Stochastic Oscillator
- FORTY 88.50
- DRRX 60.00
About FORTY Formula Systems (1985) Ltd.
Formula Systems (1985) Ltd is a holding company that, through its subsidiaries, provides information technology services. The company organizes itself into operating segments: The Matrix segment, which generates the majority of revenue, provides software development and existing software expansion services. The Sapiens segment provides software development services for the insurance industry. The Magic Software segment provides vendor management systems and workforce management services, which include accounting and finance, human resources, Michpal, ZAP Group, and Others. The majority of the company's revenue comes from Israel.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.